Both in Pharmaceuticals
Climb Bio vs Shattuck Labs
Over the past year CLYM returned +477.9% and STTK returned +188.1%; their daily moves had a correlation of 0.16.
CLYM +477.9% STTK +188.1%Growth of $1, one year, split-adjusted
| Metric | CLYM | STTK |
|---|---|---|
| Price | $11.50 | $6.54 |
| Market cap | $660.5M | $656.4M |
| Today | −2.04% | +1.71% |
| 1 month | −21.1% | −7.1% |
| 6 months | +75.8% | +9.7% |
| Year to date | +187.5% | +79.2% |
| 1 year | +439.9% | +186.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 656.4× |
| Net cash | $183.1M | $208.3M |
| Dividend yield | — | — |
| Volatility (60d) | 74.9% | 62.6% |
| Short % of float | 22.2% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).